Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Gyre Therapeutics (GYRE) Exchange Rate Effect (2023 - 2026)

Gyre Therapeutics has reported Exchange Rate Effect over the past 3 years, most recently at $127000.0 for Q4 2025.

Quarterly Exchange Rate Effect rose 149.8% to $127000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $343000.0 through Dec 2025, up 225.64% year-over-year, with the annual reading at $343000.0 for FY2025, 225.64% up from the prior year.
Exchange Rate Effect was $127000.0 for Q4 2025 at Gyre Therapeutics, up from $117000.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at $231000.0 in Q4 2023 and troughed at -$900000.0 in Q2 2023.
The 3-year median for Exchange Rate Effect is $78000.0 (2024), against an average of -$19000.0.
Year-over-year, Exchange Rate Effect crashed 210.39% in 2024 and then soared 208.7% in 2025.
A 3-year view of Exchange Rate Effect shows it stood at $231000.0 in 2023, then crashed by 210.39% to -$255000.0 in 2024, then soared by 149.8% to $127000.0 in 2025.
Per Business Quant, the three most recent readings for GYRE's Exchange Rate Effect are $127000.0 (Q4 2025), $117000.0 (Q3 2025), and $49000.0 (Q2 2025).